diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/2072-0351-5823diaendo-5823Research ArticleСтатьиArticlesАльфа-липоевая кислота в лечении непролиферативной диабетической ретинопатии.Alpha-lipoic acid in non-proliferative diabetic retinopathy treatmentДемидоваТатьяна ЮльевнаDemidovaTatiana Yul'evnat.y.demidova@gmail.ruТрахтенбергЮлия АлександровнаTrakhtenbergYulia Alexandrovna-ГБОУ ДПО Российская медицинская академия последипломного образования, МоскваRussian Medical Academy of Postgraduate Education, MoscowМедицинский центр «Диагност», МоскваMedical Centre "Diagnost", Moscow201115122011144№4 (2011)8286Copyright © Демидова Т.Ю., Трахтенберг Ю.А., 20112011Демидова Т.Ю., Трахтенберг Ю.А.Demidova T.Y., Trakhtenberg Y.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/5823сахарный диабетосложненияретинопатияdiabetes mellituscomplicationsretinopathyReferencesNational Diabetes Statistics, 2010. National Diabetes Information Clearinghouse, 2008.National Diabetes Statistics, 2010. National Diabetes Information Clearinghouse, 2008.Ingerman A., Dewey-Mattia D. Emerging Treatments for Diabetic Macular Edema // Retina Today. - 2010. - Р. 52-54.Ingerman A., Dewey-Mattia D. Emerging Treatments for Diabetic Macular Edema // Retina Today. - 2010. - Р. 52-54.Балашевич Л.И., Бржеский В.В. и др. Глазные проявления диа- бета // СпбМАПО. - 2004. - С. 123-199.Балашевич Л.И., Бржеский В.В. и др. Глазные проявления диа- бета // СпбМАПО. - 2004. - С. 123-199.Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from srereoscopic color fundus photographs - an extension of the modified Airlie House classificacion. ETDRS Report №10 // Ophthalmology. - 1991. - Vol. 98. - P. 786-806.Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from srereoscopic color fundus photographs - an extension of the modified Airlie House classificacion. ETDRS Report №10 // Ophthalmology. - 1991. - Vol. 98. - P. 786-806.Chaturvedi N., Porta M., Klein R. et al. Effect of candesartan on prevention (DIRECT-Prevent1) and progression (DIRECT-Protect1) of retinopathy in type 1 diabetes: randomized, placebo-controlled trials // Lancet. - 2008. - № 372. - Р. 1394-1402.Chaturvedi N., Porta M., Klein R. et al. Effect of candesartan on prevention (DIRECT-Prevent1) and progression (DIRECT-Protect1) of retinopathy in type 1 diabetes: randomized, placebo-controlled trials // Lancet. - 2008. - № 372. - Р. 1394-1402.ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes // N. Engl. J. Med. - 2010. - № 363. - Р. 233-244.ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes // N. Engl. J. Med. - 2010. - № 363. - Р. 233-244.Sacks F.M. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate //Am. J. Cardiol. - 2008. - 102(12A). - 34L-40L.Sacks F.M. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate //Am. J. Cardiol. - 2008. - 102(12A). - 34L-40L.Yilmaz T., Weaver C.D., Gallagher M.J. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review // Ophthalmology. - 2009. - № 116(5). - Р. 902-911.Yilmaz T., Weaver C.D., Gallagher M.J. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review // Ophthalmology. - 2009. - № 116(5). - Р. 902-911.Haller J.A., Kuppermann B.D., Blumenkranz M.S. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema // Arch. Ophthalmol. - 2010. - № 128(3). - Р. 289-296.Haller J.A., Kuppermann B.D., Blumenkranz M.S. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema // Arch. Ophthalmol. - 2010. - № 128(3). - Р. 289-296.Nicholson B.P., Schachat A.P. A review of clinical trials of anti-VEGF agents for diabetic retinopathy // Graefes Arch. Clin. Exp. Ophthalmol. - 2010. - № 248(7). - Р. 915-930.Nicholson B.P., Schachat A.P. A review of clinical trials of anti-VEGF agents for diabetic retinopathy // Graefes Arch. Clin. Exp. Ophthalmol. - 2010. - № 248(7). - Р. 915-930.Donnelly R. Vascular complications of diabetes // Blackwell Publishing. - 2005. - P. 189-213.Donnelly R. Vascular complications of diabetes // Blackwell Publishing. - 2005. - P. 189-213.Балаболкин М.И., Креминская В.М., Клебанова Е.М. Роль окисли- тельного стресса в патогенезе диабетической нейропатии и возможность его коррекции препаратами -липоевой кислоты // Проблемы эндокринологии. - 2005. - Т. 51, № 3. - С. 22-32.Балаболкин М.И., Креминская В.М., Клебанова Е.М. Роль окисли- тельного стресса в патогенезе диабетической нейропатии и возможность его коррекции препаратами -липоевой кислоты // Проблемы эндокринологии. - 2005. - Т. 51, № 3. - С. 22-32.Reljanovic M., Reichel G., Lobisch M. et al. Treatment of diabetic polyneuropathy with the antioxydant thioctic acid (alfa-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II) Alfa-lipoic acid in diabetic neuropathy // Free Radical Reseach. - 1999. -Vol. 31, P. 171-179.Reljanovic M., Reichel G., Lobisch M. et al. Treatment of diabetic polyneuropathy with the antioxydant thioctic acid (alfa-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II) Alfa-lipoic acid in diabetic neuropathy // Free Radical Reseach. - 1999. -Vol. 31, P. 171-179.Ziegler D., Hanefild M., Ruhnau K. et al. The ALADIN III Study Group. Treatment of symptomatic diabetic polyneuropathy with the antioxydant alfa-lipoic acid. A 3 week multicenter randomized controlled trial // Diabetes Care. - 1999. - Vol. 22, P. 1296-1301.Ziegler D., Hanefild M., Ruhnau K. et al. The ALADIN III Study Group. Treatment of symptomatic diabetic polyneuropathy with the antioxydant alfa-lipoic acid. A 3 week multicenter randomized controlled trial // Diabetes Care. - 1999. - Vol. 22, P. 1296-1301.Дедов И.И., Удовиченко О.В., Галстян Г.Р. Диабетическая стопа. - М.: Практическая медицина. - 2005. - С. 48.Дедов И.И., Удовиченко О.В., Галстян Г.Р. Диабетическая стопа. - М.: Практическая медицина. - 2005. - С. 48.Morcos M., Borcea V., Isermann B. et al. Effect of -lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus // Diab. Res. Clin. Pract. - 2001. - Vol. 52. - P. 175-183.Morcos M., Borcea V., Isermann B. et al. Effect of -lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus // Diab. Res. Clin. Pract. - 2001. - Vol. 52. - P. 175-183.
The authors declare that there are no conflicts of interest present.